Manish Kumar, New Delhi: Emergency use of the coronavirus vaccine has been approved in India.
The Drug Controller General of India (DCGI) has approved the emergency use of the serum institute and the Bharat Biotech vaccine. Prime Minister Narendra Modi has congratulated the scientists with a statement on Twitter.
“Every Indian would be proud that the two vaccines which have been allowed to use emergency are made in India. The Prime Minister has also praised the scientists and said that our scientific community has also shown the spirit of self-reliant India. At its core is care and compassion,” PM Modi wrote.
The Drug Controller General of India said that the coronavirus vaccine of Serum Institute of India and Bharat Biotech has been allowed to use restricted in case of emergency. In addition, DCGI has also allowed M / s Cadila Healthcare for Phase III clinical trials in India.
After the approval of the Serum Institute’s Vaccine Kovishield and Bharat Biotech Vaccine Kovaxin for emergency use, these vaccines will now be available to the general public in the country. The director of DCGI stated that both Covid-19 vaccines are completely safe and can be used in the event of an emergency. According to the DCGI, two doses of both coronavirus vaccines will be given as injections.
When the Drug Controller General of India gives its final permission, then only can these Covid-19 vaccine can be used in public. Before granting such permission, DCGI carefully studies the data on the vaccine. Only when DCGI is satisfied with this report does it allow public use of the vaccine.